Diabetes treatment is constantly progressing, with new therapeutic options emerging to improve patient outcomes. Recent investigations have focused on GLP-1 and GIP receptor agonists, a class of drugs that mimic the https://delilahlmis791493.wikiap.com/2042805/emerging_glp_1_and_gip_receptor_agonists_a_new_era_in_diabetes_treatment